KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Return on Invested Capital: 2014-2025

Historic Return on Invested Capital for Nektar Therapeutics (NKTR) over the last 4 years, with Sep 2025 value amounting to -3.21%.

  • Nektar Therapeutics' Return on Invested Capital fell 83.00% to -3.21% in Q3 2025 from the same period last year, while for Sep 2025 it was -3.21%, marking a year-over-year decrease of 83.00%. This contributed to the annual value of -1.10% for FY2024, which is 4.00% down from last year.
  • According to the latest figures from Q3 2025, Nektar Therapeutics' Return on Invested Capital is -3.21%, which was down 116.74% from 19.18% recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Return on Invested Capital peaked at 19.18% during Q2 2025, and registered a low of -3.21% during Q3 2025.
  • Over the past 3 years, Nektar Therapeutics' median Return on Invested Capital value was -1.87% (recorded in 2023), while the average stood at 0.49%.
  • Data for Nektar Therapeutics' Return on Invested Capital shows a peak YoY increase of 2,076bps (in 2025) and a maximum YoY decrease of 179bps (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Nektar Therapeutics' Return on Invested Capital stood at -1.81% in 2023, then fell by 10bps to -1.92% in 2024, then plummeted by 83bps to -3.21% in 2025.
  • Its Return on Invested Capital was -3.21% in Q3 2025, compared to 19.18% in Q2 2025 and -3.07% in Q1 2025.